Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Reported today (16 July 2018) in the journal Nature Biotechnology, the study also revealed that standard tests for detecting DNA changes miss finding this genetic damage, and that caution and specific testing will be required for any potential gene therapies.
CRISPR/Cas9 is one of the newest genome editing tools. It can alter sections of DNA in cells by cutting at specific points and introducing changes at that location. Already extensively used in scientific research, CRISPR/Cas9 has also been seen as a promising way to create potential genome editing treatments for diseases such as HIV, cancer or sickle cell disease. Such therapeutics could inactivate a disease-causing gene, or correct a genetic mutation. However, any potential treatments would have to prove that they were safe.
Previous research had not shown many unforeseen mutations from CRISPR/Cas9 in the DNA at the genome editing target site. To investigate this further the researchers carried out a full systematic study in both mouse and human cells and discovered that CRISPR/Cas9 frequently caused extensive mutations, but at a greater distance from the target site.
The researchers found many of the cells had large genetic rearrangements such as DNA deletions and insertions. These could lead to important genes being switched on or off, which could have major implications for CRISPR/Cas9 use in therapies. In addition, some of these changes were too far away from the target site to be seen with standard genotyping methods.
“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells, and we found that changes in the DNA have been seriously underestimated before now. It is important that anyone thinking of using this technology for gene therapy proceeds with caution, and looks very carefully to check for possible harmful effects.”
Professor Allan Bradley, corresponding author on the study from the Wellcome Sanger Institute
“My initial experiment used CRISPR/Cas9 as a tool to study gene activity, however it became clear that something unexpected was happening. Once we realised the extent of the genetic rearrangements we studied it systematically, looking at different genes and different therapeutically relevant cell lines, and showed that the CRISPR/Cas9 effects held true.”
Michael Kosicki, the first author from the Wellcome Sanger Institute
The work has implications for how CRISPR/Cas9 is used therapeutically and is likely to re-spark researchers’ interest in finding alternatives to the standard CRISPR/Cas9 method for gene editing.
“This study is the first to assess the repertoire of genomic damage arising at a CRISPR/Cas9 cleavage site. While it is not known if genomic sites in other cell lines will be affected in the same way, this study shows that further research and specific testing is needed before CRISPR/Cas9 is used clinically.”
Professor Maria Jasin, an independent researcher from Memorial Slone Kettering Cancer Centre, New York, who was not involved in the study
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- ‘Mini’ U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effectson March 20, 2020 at 8:19 am
RNA polymerase III (Pol III) promoters express short non-coding RNAs and have been adopted for expression of microRNA, interference RNA, and CRISPR single guide RNA (sgRNA). Vectors incorporating H1 ...
- Cas-CLOVER: The Clean Alternative to CRISPR-Cas9on March 19, 2020 at 8:01 am
The potential that gene-editing technology possesses is immense. Due to its ease of use and high efficiency, the CRISPR-Cas9 system is rapidly becoming the prevalent system for the genetic ...
- CRISPR-Cas9 Variant More Specific after Swapping One Amino Acidon March 18, 2020 at 3:00 pm
Otherwise, slip-ups are bound to happen, and you’ll mar your work—whether you’re performing carpentry or editing the genome. In the case of CRISPR-Cas9 genome editing, the equivalent of a steady hand ...
- CRISPR-Cas9: Should we be able to edit our genes?on March 12, 2020 at 5:08 pm
As of February 2020, new steps have been taken towards using this medical technology in the clinic and so these ethical concerns require urgent attention. What is CRISPR-Cas9? CRISPR-Cas9 is described ...
- Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editingon March 12, 2020 at 3:11 am
Clustered regularly interspaced short palindromic repeats-associated protein (CRISPR/Cas9) system has become a revolutionary tool for gene editing. Since viral delivery systems have significant side ...
- Cellectis receives US patent for methods of preparing allogeneic T-cells for immunotherapy with CRISPR-Cas9 technologyon March 11, 2020 at 9:30 pm
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that a new patent from the US Patent and ...
- Researchers establish new viable CRISPR-Cas12b system for plant genome engineeringon March 10, 2020 at 1:55 pm
Most people who know CRISPR are likely thinking of CRISPR-Cas9, the system that started it all. But Qi and his lab are constantly exploring new CRISPR tools that are more effective, efficient, and ...
- US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectison March 10, 2020 at 1:41 pm
This patent complements the European patent EP3004337, claiming a method of preparing T-cells for immunotherapy using the CRISPR-Cas9 system, initially granted on August 2, 2017 and upheld by the EPO ...
- New Cas9 variant reduces off-target CRISPR effectson March 9, 2020 at 8:07 am
A novel variant of the Cas9 enzyme may increase the specificity of CRISPR/Cas9 genome editing. 'An unintended cut at the wrong place in the human genome can have profound consequences,' said co-author ...
via Bing News